Evidence map›Paper›PMID 40446208›Full record

ArticleDevelopment (Cambridge, England)2025

Donor embryonic stem cells displace host cells of 8-cell-stage chimeras to the extra-embryonic lineages by spatial crowding and FGF4 signalling.

Stanley E Strawbridge, Anna Katharina Schrattel, Peter Humphreys, Kenneth A Jones, Jérôme Artus, Anna-Katerina Hadjantonakis, Alexander G Fletcher, Jennifer Nichols

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stanley E StrawbridgeCambridge Stem Cell Institute, University of Cambridge, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, UK.ORCID 0000-0003-0273-0835
Anna Katharina SchrattelCambridge Stem Cell Institute, University of Cambridge, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, UK.ORCID 0009-0009-1884-3392
Peter HumphreysCambridge Stem Cell Institute, University of Cambridge, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, UK.
Kenneth A JonesCambridge Stem Cell Institute, University of Cambridge, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, UK.
Jérôme ArtusDevelopmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0003-3423-8634
Anna-Katerina HadjantonakisDevelopmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0002-7580-5124
Alexander G FletcherSchool of Mathematical and Physical Sciences, University of Sheffield, Hicks Building, Hounsfield Road, Sheffield S3 7RH, UK.ORCID 0000-0003-0525-4336
Jennifer NicholsCambridge Stem Cell Institute, University of Cambridge, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW, UK.ORCID 0000-0002-8650-1388

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Mechanisms driving cell fate specification and morphogenesis in the blastocystR01HD094868 · NICHD · SLOAN-KETTERING INST CAN RESEARCH · PI ANNA-KATERINA HADJANTONAKIS · 2018 to 2026
$4.2M
Biotechnology and Biological Sciences Research BB/M023370/1Biotechnology and Biological Sciences Research Council BB/M023370/1Biotechnology and Biological Sciences Research Council BB/R016925/1Biotechnology and Biological Sciences Research Council BB/V018647/1Company of Biologists DEVTF-180513Medical Research Council MC_PC_17230NCI NIH HHS P30 CA008748NICHD NIH HHS R01 HD094868NIH HHS P30CA008748NIH HHS R01HD094868UK Research and Innovation MC_PC_17230University of CambridgeUniversity of SheffieldWellcome 224070/Z/21/ZWellcome TrustWellcome Trust 203151/A/16/ZWellcome Trust 203151/Z/16/ZWellcome Trust 224070/Z/21/Z
6 · The paper itself

Abstract

Following mouse embryo compaction, outer cells become trophectoderm, while inner cells form the inner cell mass (ICM), later differentiating into primitive endoderm and epiblast during blastocyst formation. Trophectoderm specification is driven by position-governed polarisation, while primitive endoderm specification is positively regulated by FGF4 signalling from the unspecified ICM and epiblast. When injected into an 8-cell-stage morula, embryonic stem cells (ESCs; derived from pre-implantation epiblast cells in vitro) can exclude host cells from the epiblast, leading to mice derived entirely from these cells. While evidence suggests roles for ESC-produced FGF4 and physical crowding in host cell displacement from the ICM, the interplay between these possible mechanisms has yet to be dissected, in part due to the lack of studies using Fgf4-/- ESCs. Here, we combine chimera titration assays with mathematical modelling to study these mechanisms of host cell displacement. Both Fgf4+/+ and Fgf4-/- ESCs displaced host cells from the epiblast, while only Fgf4-/- ESC-injected embryos reduced primitive endoderm and increased trophectoderm, indicating sequential exclusion by displacement crowding followed by FGF4 signalling.

Indexed as

Cell LineageChimeraEmbryonic Stem CellsFibroblast Growth Factor 4Mouse Embryonic Stem CellsSignal TransductionAnimalsBlastocystCell DifferentiationEmbryo, MammalianEndodermGerm LayersMiceFgf4 protein, mouseFibroblast Growth Factor 4Bayesian inferenceEpiblastMathematical modellingMouse embryoPrimitive endodermTrophectoderm

Identifiers

PMID40446208
PMCPMC12273629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.